Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Our Products
MouseAtlas
iPSC Cell Lines
Knockout Cell Lines
Tumor Cell Lines
Adeno-associated Virus (AAV) Standard Capsid
Featured Catalog
Humanized Mouse Models
HUGO-GT™
HUGO-Ab™
Humanized Target Gene Models
Humanized Immune System Mouse Models
Tool Mice
Cre Mouse Lines
Disease Models
Autoimmune Disease Models
Ophthalmic Disease Models
Immunodeficient Mouse Models
Metabolic Disease Models
Neurological Disease Models
Oncology & Immuno-oncology Models
Services
Model Generation Techniques
Turboknockoutᵀᴹ Gene Targeting
Cre-ESCs Gene Editing
Targeted Gene Editing
Genetically Engineered Animals
Knockin Mice
Knockin Rats
Knockout Mice
Knockout Rats
Transgenic Mice
Transgenic Rats
Transgenic Model Generation
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Adenovirus Packaging
Lentivirus Packaging
Custom Cell Line Services
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Overexpression Cell Lines
Point Mutation Cell Lines
Breeding & Supporting Services
BAC Modification
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
Drug Discovery and Development
Antibody Discovery Platform
HUGO-Ab™
HUGO-Mab™
HUGO-Light™
HUGO-Nano™
HUGO-Ab-eKO™
Therapeutic Area
Neurology
Alzheimer's Disease (AD)
Parkinson's Disease (PD)
Huntington's Disease (HD)
Blood Brain Barrier (BBB)
Metabolic & Cardiovascular
Obesity
Ophthalmology
Glaucoma
Age-Related Macular Degeneration (AMD)
Oncology
PBMC Humanized Mouse Model
Human Immune System (HIS) Mouse Model
Immunology & Inflammation
Asthma
Innovative Drug R&D
Therapeutic Antibody Drugs
Monoclonal Antibodies (mAb)
Bispecific Antibodies (BsAb)
ADC/AOC
AI-Powered AAV Discovery
Cell Immunotherapy
Gene Therapy
Oligonucleotide Therapy
Fully Human Antibody Library
Neurology Antibodies
Metabolic & Cardiovascular Antibodies
Ophthalmology Antibodies
Oncology Antibodies
Immunology & Inflammation Antibodies
Resources
News
Blogs & Insight
Promotion
Events & Webinars
Databases
AbSeek
Rare Disease Data Center
Cell iGeneEditor™ System
Citations
Resource Vault
OriCell
About Us
Animal Health & Welfare
Corporate Overview
Facility Overview
Our Team
Our Partners
Careers
Health Reports
Contact Us
Login
HomeMouseAtlas
C57BL/6JCya-Mospd1em1flox/Cya
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
+
-
Organization
Job Role
Country
Catalog Type
Product Name
Main Area of Research
How did you hear about us?
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.

C57BL/6JCya-Mospd1em1flox/Cya

Common Name
Mospd1-flox
Product ID
S-CKO-14803
Backgroud
C57BL/6JCya
Strain ID
CKOCMP-70380-Mospd1-B6J-VA
Status
Research and Development
When using this mouse strain in a publication, please cite “Mospd1-flox Mouse (Catalog S-CKO-14803) were purchased from Cyagen.”
cKO Models
Product Type
Age
Genotype
Sex
Quantity
The standard delivery applies for a guaranteed minimum of three heterozygous carriers. Breeding services for homozygous carriers and/or specified sex are available.
+
cKO Models
Basic Information
Strain Name
Mospd1-flox
Strain ID
CKOCMP-70380-Mospd1-B6J-VA
Gene Name
Mospd1
Product ID
S-CKO-14803
Gene Alias
1810018L05Rik
Background
C57BL/6JCya
Gene Full Name
motile sperm domain containing 1
Modification
Conditional knockout
NCBI ID
70380 (Mouse)
Phenotype
MGI:1917630
Chromosome
Chr X (Mouse)
Application
--
Datasheet
Click here to download >>
More
Rare Disease Data Center >>
Strain Description
Ensembl Transcript ID
ENSMUST00000023836
NCBI Transcript ID
NM_027409
Target Region
Exon 4
Size of Effective Region
~1.9 kb
Overview of Gene Research
MOSPD1, Motile Sperm Domain-Containing Protein 1, is part of a gene family including Mospd2 and Mospd3, characterized by the major sperm protein domain and two transmembrane domains. It is located in the endoplasmic reticulum and Golgi apparatus, and can localize to the nucleus under certain conditions [2]. MOSPD1 may play roles in membrane contact sites as it can interact with FFAT-related FFNT motifs [4,5,7]. It is involved in multiple biological processes, and its dysregulation is associated with various diseases.

In breast cancer, MOSPD1 expression is significantly higher in cancer samples than normal tissues, correlating with poor clinical outcomes. MOSPD1 suppression inhibits tumor growth, while overexpression accelerates it. Silencing MOSPD1 also enhances breast cancer cell sensitivity to anti-PD-L1 therapy and decreases Th2 cell activity [1].

In gastric cancer, MOSPD1 promotes cancer progression by facilitating fatty acid metabolism through activating the MAPK pathway. MOSPD1 knockdown decreases the proliferation, migration, and invasion of gastric cancer cells [3].

In mesenchymal stem cells (MSCs), MOSPD1-null embryonic stem cells are deficient in differentiating into several cell lineages including osteoblasts, adipocytes, and hematopoietic progenitors, and the growth rate of MSC-like cells derived from MOSPD1-null ESCs is significantly impaired [6].

In colorectal cancer, MOSPD1 is upregulated by the Wnt/β-catenin signaling pathway [8].

In conclusion, MOSPD1 is crucial in multiple biological processes such as cell differentiation and proliferation. Its dysregulation significantly impacts the development and progression of various cancers, including breast, gastric, and colorectal cancer. The use of gene knockout models in mice has been instrumental in revealing these functions, providing potential therapeutic targets for these diseases.

References:
1. Jiang, Yiling, Li, Hailong, Wu, Sixuan, Du, Wei, Li, Yuehua. 2024. Deciphering MOSPD1's impact on breast cancer progression and therapeutic response. In Biology direct, 19, 88. doi:10.1186/s13062-024-00531-9. https://pubmed.ncbi.nlm.nih.gov/39369222/
2. Thaler, R, Rumpler, M, Spitzer, S, Klaushofer, K, Varga, F. . Mospd1, a new player in mesenchymal versus epidermal cell differentiation. In Journal of cellular physiology, 226, 2505-15. doi:10.1002/jcp.22595. https://pubmed.ncbi.nlm.nih.gov/21792907/
3. Wang, Chengliang, Qiu, Yunping, Zheng, Xiao, Chen, Shuhui, He, Chao. 2025. MOSPD1 facilitates fatty acid metabolism and gastric cancer progression by promoting the MAPK pathway. In Tissue & cell, 93, 102752. doi:10.1016/j.tice.2025.102752. https://pubmed.ncbi.nlm.nih.gov/39864210/
4. Cabukusta, Birol, Berlin, Ilana, van Elsland, Daphne M, van Veelen, Peter A, Neefjes, Jacques. . Human VAPome Analysis Reveals MOSPD1 and MOSPD3 as Membrane Contact Site Proteins Interacting with FFAT-Related FFNT Motifs. In Cell reports, 33, 108475. doi:10.1016/j.celrep.2020.108475. https://pubmed.ncbi.nlm.nih.gov/33296653/
5. Cabukusta, Birol, Berlin, Ilana, van Elsland, Daphne M, van Veelen, Peter A, Neefjes, Jacques. 2023. Human VAPome Analysis Reveals MOSPD1 and MOSPD3 as Membrane Contact Site Proteins Interacting with FFAT-Related FFNT Motifs. In Cell reports, 42, 112849. doi:10.1016/j.celrep.2023.112849. https://pubmed.ncbi.nlm.nih.gov/37440407/
6. Kara, Madina, Axton, Richard A, Jackson, Melany, Peault, Bruno, Forrester, Lesley M. 2015. A Role for MOSPD1 in Mesenchymal Stem Cell Proliferation and Differentiation. In Stem cells (Dayton, Ohio), 33, 3077-86. doi:10.1002/stem.2102. https://pubmed.ncbi.nlm.nih.gov/26175344/
7. James, Christina, Kehlenbach, Ralph H. 2021. The Interactome of the VAP Family of Proteins: An Overview. In Cells, 10, . doi:10.3390/cells10071780. https://pubmed.ncbi.nlm.nih.gov/34359948/
8. Horie, Chiaki, Zhu, Chi, Yamaguchi, Kiyoshi, Shida, Dai, Furukawa, Yoichi. 2022. Motile sperm domain containing 1 is upregulated by the Wnt/β-catenin signaling pathway in colorectal cancer. In Oncology letters, 24, 282. doi:10.3892/ol.2022.13402. https://pubmed.ncbi.nlm.nih.gov/35814826/
Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Contact Us
Connect with our experts for your custom animal model needs. Please fill out the form below to start a conversation or request a quote.
Inquiry Details
Main Area of Research
Service(s) of Interest
Gene of Interest
Project Details
How did you hear about us?
Contact Information
Full Name
Email
Phone Number
+
-
Organization
Job Role
Country
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our  Privacy Policy  for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0336
Email:
inquiry@cyagen.com
Services
HUGO-GT™HUGO-Ab™iPSC Cell LinesAdeno-associated Virus (AAV) Standard Capsid
Drug R&D
NeurologyMetabolicOphthalmologyOncology
About Us
Animal Health & WelfareCorporate OverviewOur TeamHealth Reports
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Global Antibody Drug Industry Development BlueBook (Frost & Sullivan)
Key Insights
The industry is undergoing a rapid transformation driven by next-generation modalities, globalized markets, and upstream technological innovations.
  • Market Structural Shift: Monoclonal antibodies drive steady growth, but ADCs and bispecifics are rapidly accelerating, reshaping the market with higher-value innovations.
  • Chinese Market Globalization: China is actively expanding globally, evidenced by a surge in high-value cross-border license-out deals.
  • Technology-Driven Efficiency: Advanced discovery engines—exemplified by Cyagen's HUGO-Ab platform and AI algorithms—are streamlining candidate screening, optimizing molecular design, and localizing the upstream supply chain.
  • Oncology-Focused Innovation: R&D pipelines remain heavily concentrated on high-incidence malignancies like non-small cell lung cancer, utilizing complex modalities to combat clinical resistance.
Now Available for Download
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest
Main Area of Research